{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:05:28Z","timestamp":1790881528798,"version":"4.1.0"},"reference-count":0,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can. J. Neurol. Sci."],"abstract":"ABSTRACT<\/jats:title>\n \n Background:<\/jats:title>\n Status epilepticus (SE) is a neurologic emergency characterized by prolonged or recurrent seizures leading to significant secondary brain injury, complications, morbidity and mortality. Timely and aggressive management is paramount to mitigate this disease burden, but response rates to first- and second-line antiseizure medications (ASMs) remain suboptimal. Cenobamate (CBM), a novel ASM, has shown great promise in clinical trials as an adjunctive agent for patients with refractory focal epilepsy, but little is known about its efficacy and safety for SE.<\/jats:p>\n <\/jats:sec>\n \n Objective:<\/jats:title>\n This systematic review aims to evaluate the efficacy and safety of CBM for managing SE, refractory SE and super-refractory SE (SRSE).<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed. A literature search was conducted across MEDLINE, EMBASE, CINAHL and Cochrane CENTRAL. Original research involving adult patients with SE treated with CBM were included, and study quality was assessed. Data on patient demographics, treatment protocols and outcomes were extracted.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Of 62 articles screened, 4 studies met the inclusion criteria, comprising 2 full manuscripts and 2 conference abstracts. A total of five patients with SRSE were treated with CBM. Seizure cessation was observed in two patients (40%). Reported adverse events included somnolence and gastrointestinal disturbances.<\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n Evidence supporting the use of CBM for the management of patients with SE is limited. Further structured studies are needed to establish optimal dosing, efficacy and safety of CBM for patients with SE.<\/jats:p>\n <\/jats:sec>","DOI":"10.1017\/cjn.2026.10651","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:16:31Z","timestamp":1783926991000},"page":"1-9","source":"Crossref","is-referenced-by-count":1,"title":["Cenobamate for Status Epilepticus: A Systematic Review"],"prefix":"10.1017","author":[{"given":"Moses","family":"Mo","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03yjb2x39","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Calgary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Howard","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03yjb2x39","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Calgary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Jaworska","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03yjb2x39","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Calgary"},{"id":[{"id":"https:\/\/ror.org\/02nt5es71","id-type":"ROR","asserted-by":"publisher"}],"name":"Alberta Health Services"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8993-0009","authenticated-orcid":false,"given":"Caralyn","family":"Bencsik","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03yjb2x39","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Calgary"},{"id":[{"id":"https:\/\/ror.org\/02nt5es71","id-type":"ROR","asserted-by":"publisher"}],"name":"Alberta Health Services"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ish","family":"Bains","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03yjb2x39","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Calgary"},{"id":[{"id":"https:\/\/ror.org\/02nt5es71","id-type":"ROR","asserted-by":"publisher"}],"name":"Alberta Health Services"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8850-9095","authenticated-orcid":false,"given":"Julie Anne","family":"Kromm","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03yjb2x39","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Calgary"},{"id":[{"id":"https:\/\/ror.org\/02nt5es71","id-type":"ROR","asserted-by":"publisher"}],"name":"Alberta Health Services"},{"id":[{"id":"https:\/\/ror.org\/03yjb2x39","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Calgary"},{"id":[{"id":"https:\/\/ror.org\/03k51z204","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Calgary Hotchkiss Brain Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2026,7,13]]},"container-title":["Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0317167126106519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T05:03:26Z","timestamp":1788757406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0317167126106519\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":0,"alternative-id":["S0317167126106519"],"URL":"https:\/\/doi.org\/10.1017\/cjn.2026.10651","relation":{},"ISSN":["0317-1671","2057-0155"],"issn-type":[{"value":"0317-1671","type":"print"},{"value":"2057-0155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]}}}